Kyverna Therapeutics Competitors and Similar CompaniesClear all
Jazz Pharmaceuticals's competitors and similar companies include Spexis.
 Jazz Pharmaceuticals Jazz Pharmaceuticals is a biopharmaceutical company engaged in developing and marketing medicines for sleep disorders, epilepsy, and oncology. |  Spexis Spexis (formerly known as Polyphor) is a bioengineering company that specializes in respiratory therapeutics. | |
Founding Date | Founding Date 2003 | Founding Date 1996 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations Dublin, IE HQ Mississauga, CA Vancouver, CA Lyon, FR München, DE Roscommon, IE Villa Guardia, IT see more | Locations Allschwil, CH HQ |
Employees | Employees 2,800 | Employees 50 |
Financial | ||
Revenue (est.) | Revenue (est.) $4.3b (FY, 2025) | Revenue (est.) N/A |
Net income | Net income ($356.1m) (FY, 2025) | Net income (CHF19.6m) (FY, 2023) |
For sources of this data, please see the company profile
View Company Profiles
Spexis
HQ
Allschwil, CH
Employees
50
Spexis (formerly known as Polyphor) is a bioengineering company that specializes in respiratory therapeutics.
View company